Defective T-cell proliferation and IL-2 production in a subgroup of patients with coronary artery disease

Iranian Journal of Allergy, Asthma and Immunology

Volumn 9, Issue 3, 2010, Pages 133-140

  Mahmoudi, Maryam ^a   Siassi, Fereydoon ^a   Mahmoudi, Mohammad Jafar ^a   Eshraghian, Mohammad Reza ^a   Zarnani, Amir Hassan ^b,c   Rezaei, Nima ^a,d   Hedayat, Mona ^a   Shokri, Fazel ^a   Saboor Yaraghi, Ali Akbar ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b AVICENNA RESEARCH INSTITUTE   (Iran)

^c IRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Atherosclerosis; Interleukin 2; Peripheral blood mononuclear cells; Proliferation

Indexed keywords

INTERLEUKIN 2; PHYTOHEMAGGLUTININ;

ADULT; ARTICLE; ATHEROSCLEROSIS; CELL CULTURE; CELL PROLIFERATION; CELL VIABILITY; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CYTOKINE PRODUCTION; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; MALE; MITOGENESIS; OPTICAL DENSITY; PERIPHERAL BLOOD MONONUCLEAR CELL; T LYMPHOCYTE; DRUG EFFECTS; IMMUNOLOGY; MONONUCLEAR CELL;

CELL PROLIFERATION; CORONARY ARTERY DISEASE; HUMANS; INTERLEUKIN-2; LEUKOCYTES, MONONUCLEAR; PHYTOHEMAGGLUTININS;

EID: 78049454843     PISSN: 17351502     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Hansson GK, Libby P. The immune response in atherosclerosis: a double-edged sword. Nat Rev Immunol 2006; 6(7):508-19. (Pubitemid 43980523)
2. Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 2005; 352(16):1685-95.
3. Lundberg AM, Hansson GK. Innate immune signals in atherosclerosis. Clin Immunol 2010; 134(1):5-24.
4. Andersson J, Libby P, Hansson GK. Adaptive immunity and atherosclerosis. Clin Immunol 2010; 134(1):33-46.
5. Skalen K, Gustafsson M, Rydberg EK, Hulten LM, Wiklund O, Innerarity TL, et al. Subendothelial retention of atherogenic lipoproteins in early atherosclerosis. Nature 2002; 417(6890):750-4. (Pubitemid 34640629)
6. Berliner JA, Heinecke JW. The role of oxidized lipoproteins in atherogenesis. Free Radic Biol Med 1996; 20(5):707-27.
7. Nakashima Y, Raines EW, Plump AS, Breslow JL, Ross R. Upregulation of VCAM-1 and ICAM-1 at atherosclerosis-prone sites on the endothelium in the ApoE-deficient mouse. Arterioscler Thromb Vasc Biol 1998; 18(5):842-51. (Pubitemid 28267666)
8. Boring L, Gosling J, Cleary M, Charo IF. Decreased lesion formation in CCR2-/- mice reveals a role for chemokines in the initiation of atherosclerosis. Nature 1998; 394(6696):894-7. (Pubitemid 28410911)
9. Gu L, Okada Y, Clinton SK, Gerard C, Sukhova GK, Libby P, et al. Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low density lipoprotein receptor-deficient mice. Mol Cell 1998; 2(2):275-81. (Pubitemid 128373654)
10. Edfeldt K, Swedenborg J, Hansson GK, Yan ZQ. Expression of toll-like receptors in human atherosclerotic lesions: a possible pathway for plaque activation. Circulation 2002; 105(10):1158-61. (Pubitemid 34225814)
11. Bobryshev YV. Dendritic cells in atherosclerosis: current status of the problem and clinical relevance. Eur Heart J 2005; 26(17):1700-4.
12. McLaren JE, Ramji DP. Interferon gamma: a master regulator of atherosclerosis. Cytokine Growth Factor Rev 2009; 20(2):125-35.
13. Stemme S, Holm J, Hansson GK. T lymphocytes in human atherosclerotic plaques are memory cells expressing CD45RO and the integrin VLA-1. Arterioscler Thromb 1992; 12(2):206-11.
14. Paulsson G, Zhou X, Tornquist E, Hansson GK. Oligoclonal T cell expansions in atherosclerotic lesions of apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol 2000; 20(1):10-7. (Pubitemid 30048341)
15. Gaffen SL, Liu KD. Overview of interleukin-2 function, production and clinical applications. Cytokine 2004; 28(3):109-23.
16. Ho IC, Kim JI, Szabo SJ, Glimcher LH. Tissue-specific regulation of cytokine gene expression. Cold Spring Harb Symp Quant Biol 1999; 64:573-84.
17. Upadhya S, Mooteri S, Peckham N, Pai RG. Atherogenic effect of interleukin-2 and antiatherogenic effect of interleukin-2 antibody in apo-E-deficient mice. Angiology 2004; 55(3):289-94. (Pubitemid 38649693)
18. Mazzone A, De Servi S, Vezzoli M, Fossati G, Mazzucchelli I, Gritti D, et al. Plasma levels of interleukin 2, 6, 10 and phenotypic characterization of circulating T lymphocytes in ischemic heart disease. Atherosclerosis 1999; 145(2):369-74.
19. Mizia-Stec K, Gasior Z, Zahorska-Markiewicz B, Janowska J, Szulc A, Jastrzebska-Maj E, et al. Serum tumour necrosis factor-alpha, interleukin-2 and interleukin-10 activation in stable angina and acute coronary syndromes. Coron Artery Dis 2003; 14(6):431-8. (Pubitemid 37070321)
20. Annovazzi A, Bonanno E, Arca M, D'Alessandria C, Marcoccia A, Spagnoli LG, et al. 99mTc-interleukin-2 scintigraphy for the in vivo imaging of vulnerable atherosclerotic plaques. Eur J Nucl Med Mol Imaging 2006; 33(2):117-26. (Pubitemid 43152877)
21. Calder PC. Immunological parameters: what do they mean? J Nutr 2007; 137(3 Suppl 2):773S-80S.
22. Menendez JL, Giron JA, Manzano L, Garrido A, Abreu L, Albillos A, et al. Deficient interleukin-2 responsiveness of T lymphocytes from patients with primary biliary cirrhosis. Hepatology 1992; 16(4):931-6.
23. Manzano L, Alvarez-Mon M, Vargas JA, Giron JA, Abreu L, Fernandez-Corugedo A, et al. Deficient interleukin 2 dependent proliferation pathway in T lymphocytes from active and inactive ulcerative colitis patients. Gut 1994; 35(7):955-60. (Pubitemid 24202727)
24. Roman LI, Manzano L, De La Hera A, Abreu L, Rossi I, Alvarez-Mon M. Expanded CD4+CD45RO+ phenotype and defective proliferative response in T lymphocytes from patients with Crohn's disease. Gastroenterology 1996; 110(4):1008-19. (Pubitemid 26113738)
25. Hernandez-Fuentes MP, Reyes E, Prieto A, Zea A, Villa L, Sanchez-Atrio A, et al. Defective proliferative response of T lymphocytes from patients with inactive systemic lupus erythematosus. J Rheumatol 1999; 26(7):1518-26. (Pubitemid 29317874)
26. Garcia-Suarez J, Prieto A, Manzano L, Reyes E, Molto L, Alvarez-Mon M. T lymphocytes from autoimmune thrombocytopenic purpura show a defective activation and proliferation after cytoplasmic membrane and intracytoplasmic mitogenic signals. Am J Hematol 1993; 44(1):1-8. (Pubitemid 23245052)
27. Mandal K, Jahangiri M, Xu Q. Autoimmune mechanisms of atherosclerosis. Handb Exp Pharmacol 2005; (170):723-43.
28. Matsuura E, Kobayashi K, Matsunami Y, Shen L, Quan N, Makarova M, et al. Autoimmunity, infectious immunity, and atherosclerosis. J Clin Immunol 2009; 29(6):714-21.
29. Hoyer KK, Dooms H, Barron L, Abbas AK. Interleukin-2 in the development and control of inflammatory disease. Immunol Rev 2008; 226:19-28.
30. Gillis S, Ferm MM, Ou W, Smith KA. T cell growth factor: parameters of production and a quantitative microassay for activity. J Immunol 1978; 120(6):2027-32. (Pubitemid 8356952)
31. Gesbert F, Sauvonnet N, Dautry-Varsat A. Clathrin-Independent endocytosis and signalling of interleukin 2 receptors IL-2R endocytosis and signalling. Curr Top Microbiol Immunol 2004; 286:119-48. (Pubitemid 38955149)
32. Smith KA, Popmihajlov Z. The quantal theory of immunity and the interleukin-2-dependent negative feedback regulation of the immune response. Immunol Rev 2008; 224:124-40.
33. Refaeli Y, Van Parijs L, London CA, Tschopp J, Abbas AK. Biochemical mechanisms of IL-2-regulated Fas-mediated T cell apoptosis. Immunity 1998; 8(5):615-23. (Pubitemid 28264752)
34. Fontenot JD, Rasmussen JP, Gavin MA, Rudensky AY. A function for interleukin 2 in Foxp3-expressing regulatory T cells. Nat Immunol 2005; 6(11):1142-51.
35. Pandiyan P, Zheng L, Ishihara S, Reed J, Lenardo MJ. CD4+CD25+Foxp3+ regulatory T cells induce cytokine deprivation-mediated apoptosis of effector CD4+ T cells. Nat Immunol 2007; 8(12):1353-62.
36. Laurence A, Tato CM, Davidson TS, Kanno Y, Chen Z, Yao Z, et al. Interleukin-2 signaling via STAT5 constrains T helper 17 cell generation. Immunity 2007; 26(3):371-81. (Pubitemid 46413906)
37. Bettelli E, Oukka M, Kuchroo VK. T(H)-17 cells in the circle of immunity and autoimmunity. Nat Immunol 2007; 8(4):345-50.
38. Taleb S, Tedgui A, Mallat Z. Regulatory T-cell immunity and its relevance to atherosclerosis. J Intern Med 2008; 263(5):489-99.